Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Published 31/03/2023, 17:47
Updated 31/03/2023, 19:10
© Reuters. Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga - Gainers

  • Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
  • Inpixon (NASDAQ: INPX) jumped 37.9% to $0.5101. Inpixon reported a 21% growth in revenue to $19.4 million for the 2022 fiscal year.
  • Toro Corp. (NASDAQ: TORO) surged 31.6% to $3.12.
  • Guardforce AI Co., Limited (NASDAQ: GFAI) gained 27% to $6.00.
  • IonQ, Inc. (NYSE: IONQ) rose 25.8% to $6.39 after clocking upbeat fourth-quarter results.
  • FOXO Technologies Inc. (NASDAQ: FOXO) gained 24.4% to $0.4612 following full year 2022 results.
  • Metropolitan Bank Holding Corp. (NYSE: MCB) gained 23% to $31.18 after the company issued updated financial information.
  • Palisade Bio, Inc. (NASDAQ: PALI) gained 22% to $3.23. Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target.
  • Ault Alliance, Inc. (NASDAQ: AULT) surged 20% to $0.1126 after the company announced a share buyback of up to 333,333,333 shares of common stock at $0.15 per sare through an exchange offer for a new class of preferred stock.
  • Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) gained 19.2% to $2.98. BrainStorm Cell Therapeutics recently posted a 2022 net loss per share of $0.66.
  • GT Biopharma, Inc. (NASDAQ: GTBP) gained 19% to $0.55. GT Biopharma posted a FY22 loss of $0.66 per share.
  • ASP Isotopes Inc. (NASDAQ: ASPI) surged 18% to $1.05.
  • Rigetti Computing, Inc. (NASDAQ: RGTI) surged 17.8% to $0.7070. Rigetti Computing recently posted a Q1 loss of $0.19 per share.
  • D-Wave Quantum Inc. (NYSE: QBTS) climbed 15.5% to $0.60. D-Wave Quantum announced earnings report date change for Q4 and FY22 results to the week of April 10, 2023.
  • Cabaletta Bio, Inc. (NASDAQ: CABA) gained 14.7% to $8.15. Cabaletta Bio received FDA clearance of IND application for CABA-201 for treatment of systemic lupus erythematosus.
  • Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) jumped 14% to $2.4195.
  • BlackBerry Limited (NYSE: BB) gained 13.8% to $4.5550 after the company reported better-than-expected Q4 adjusted EPS results.
  • Inozyme Pharma, Inc. (NASDAQ: INZY) surged 13.8% to $5.34. Inozyme Pharma Director Robert Hopfner acquired a total of 344,592 shares at an average price of $4.54.
  • AngioDynamics, Inc. (NASDAQ: ANGO) jumped 11.4% to $10.14. AngioDynamics recently reported worse-than-expected Q3 revenue and reduced its 2023 revenue guidance.
  • Marqeta, Inc. (NASDAQ: MQ) rose 11% to $4.6250.
  • Digital Ally, Inc. (NASDAQ: DGLY) gained 9.2% to $4.16.
  • TORM plc (NASDAQ: TRMD) surged 8.3% to $30.90 after the company reported termination of secondary public offering of its Class A common shares by a selling shareholder.
  • Digital World Acquisition Corp. (NASDAQ: DWAC) gained 6.8% to $13.95 following the indictment of Donald Trump. Digital World is the business combination partner of Trump Media & Technology Group.
  • Rumble Inc. (NASDAQ: RUM) shares climbed 6% to $9.89 after the company reported better-than-expected Q4 results and a 142% year-over-year increase in global MAUs.
Losers
  • Gorilla Technology Group Inc. (NASDAQ: GRRR) dipped 66% to $4.0150.
  • G Medical Innovations Holdings Ltd (NASDAQ: GMVD) fell 43% to $0.9354. G Medical Innovations Holdings announced pricing of $9.6 million public offering of 12 million shares of common stock at a price of $0.80 per share.
  • Virgin Orbit Holdings, Inc. (NASDAQ: VORB) fell 41.4% to $0.1994 on reports the company is ceasing operations for the foreseeable future and cutting nearly 90% of its workforce.
  • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) shares fell 40% to $1.9090 after the company reported Q4 results and announced pricing of $10.8 million underwritten public offering of common stock.
  • Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) dropped 39.7% to $2.02. Checkpoint Therapeutics announced $6.1 million registered direct offering priced at-the-market under Nasdaq rules.
  • Pyxis Oncology, Inc. (NASDAQ: PYXS) fell 28.8% to $4.27.
  • Bioventus Inc. (NASDAQ: BVS) dropped 28% to $0.8721 following weaker-than-expected quarterly results.
  • Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) dipped 27.7% to $0.3038.
  • Bit Brother Limited (NASDAQ: BTB) fell 24% to $0.8584.
  • Professional Diversity Network, Inc. (NASDAQ: IPDN) dropped 24% to $3.22.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) declined 23.6% to $5.19. Ensysce Biosciences posted a Q4 loss of $1.52 per share.
  • AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) dropped 22.7% to $4.24.
  • GAN Limited (NASDAQ: GAN) fell 22.4% to $1.3199 following a wider-than-expected quarterly loss.
  • CuriosityStream Inc. (NASDAQ: CURI) fell 22% to $1.2488 after the company reported downbeat quarterly results.
  • Apollomics Inc. (NASDAQ: APLM) dropped 21.8% to $23.00.
  • Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) fell 21.8% to $0.25.
  • AST SpaceMobile, Inc. (NASDAQ: ASTS) shares fell 21.2% to $5.04 after the company posted a wider Q4 loss.
  • Shapeways Holdings, Inc. (NYSE: SHPW) fell 20.6% to $0.3255 after the company reported weaker-than-expected results for its fourth quarter.
  • Annovis Bio, Inc. (NYSE: ANVS) dipped 20.4% to $16.00. Annovis Bio received interim analysis for sample size re-estimation for its Phase 3 clinical trial for treatment of early Parkinson's disease.
  • FaZe Holdings Inc. (NASDAQ: FAZE) fell 20.3% to $0.47. FaZe Holdings posted Q4 sales of $21.40 million.
  • ContraFect Corporation (NASDAQ: CFRX) dropped 18.7% to $1.78. ContraFect posted a Q4 loss of $16.14 per share.
  • Cano Health, Inc. (NYSE: CANO) fell 17.9% to $0.9272. Cano Health said it was disappointed that three directors chose to resign.
  • Charah Solutions, Inc. (NYSE: CHRA) dropped 17.8% to $2.16.
  • Nogin, Inc. (NASDAQ: NOGN) fell 16.2% to $2.90.
  • Siyata Mobile Inc. (NASDAQ: SYTA) dropped 15.6% to $0.1595.
  • Disc Medicine Opco Inc (NASDAQ: IRON) fell 15% to $18.69 after the company reported full year 2022 financial results.
  • Advent Technologies Holdings, Inc. (NASDAQ: ADN) fell 14.6% to $0.9994. Advent Technologies reported fourth-quarter FY22 revenue of $1.96 million, down 22% year-over-year.
  • Zura Bio Limited (NASDAQ: ZURA) dropped 14.4% to $13.55.
  • SHF Holdings, Inc. (NASDAQ: SHFS) shares fell 13.4% to $0.5189. SHF Hldgs posted a Q4 loss of $1.94 per share.
  • Aehr Test Systems (NASDAQ: AEHR) dropped 12.5% to $32.56 following Q3 results.
  • Nikola Corporation (NASDAQ: NKLA) fell 12.5% to $1.22 after the company announced pricing for a $100 million common stock offering.
  • E-Home Household Service Holdings Limited (NASDAQ: EJH) fell 12.4% to $0.1050 after dropping 9% on Thursday.
  • IGM Biosciences, Inc. (NASDAQ: IGMS) fell 12% to $14.98 after the company reported Q4 financial results.
  • TROOPS, Inc. (NASDAQ: TROO) dropped 7.7% to $3.23.
Now Read This: Top 5 Industrials Stocks That Could Lead To Your Biggest Gains In March

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.